Missing generic hurts Rite Aid

Lower reimbursement rates are eating into Rite Aid's financial outlook. Bloomberg reports that this was just one reason the drugstore chain cited for dialing back its full-year forecast. Another: the FDA ban on four Ranbaxy plants means generic Nexium is a no-show, adding to the chain's financial pain.


Next Article in Channel